SKIN vs. ANIK, PLSE, NVRO, OSUR, BVS, NPCE, SRDX, LUNG, TCMD, and CERS
Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include Anika Therapeutics (ANIK), Pulse Biosciences (PLSE), Nevro (NVRO), OraSure Technologies (OSUR), Bioventus (BVS), NeuroPace (NPCE), Surmodics (SRDX), Pulmonx (LUNG), Tactile Systems Technology (TCMD), and Cerus (CERS). These companies are all part of the "surgical & medical instruments" industry.
Beauty Health (NASDAQ:SKIN) and Anika Therapeutics (NASDAQ:ANIK) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, community ranking, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.
Beauty Health has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Anika Therapeutics has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500.
Anika Therapeutics has lower revenue, but higher earnings than Beauty Health. Anika Therapeutics is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, Beauty Health had 25 more articles in the media than Anika Therapeutics. MarketBeat recorded 42 mentions for Beauty Health and 17 mentions for Anika Therapeutics. Beauty Health's average media sentiment score of 0.95 beat Anika Therapeutics' score of 0.44 indicating that Beauty Health is being referred to more favorably in the media.
Anika Therapeutics received 260 more outperform votes than Beauty Health when rated by MarketBeat users. Likewise, 64.38% of users gave Anika Therapeutics an outperform vote while only 48.78% of users gave Beauty Health an outperform vote.
93.3% of Beauty Health shares are held by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are held by institutional investors. 41.7% of Beauty Health shares are held by insiders. Comparatively, 5.9% of Anika Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Beauty Health has a net margin of -20.48% compared to Anika Therapeutics' net margin of -45.39%. Anika Therapeutics' return on equity of 0.48% beat Beauty Health's return on equity.
Beauty Health presently has a consensus target price of $6.29, suggesting a potential upside of 129.83%. Anika Therapeutics has a consensus target price of $29.50, suggesting a potential upside of 15.41%. Given Beauty Health's higher probable upside, analysts plainly believe Beauty Health is more favorable than Anika Therapeutics.
Summary
Beauty Health beats Anika Therapeutics on 11 of the 18 factors compared between the two stocks.
Get Beauty Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beauty Health Competitors List
Related Companies and Tools
